North Star Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

North Star Investment Management’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12	Hold	7	–	–	﹤0.01%	1697
2025 Q4	$12	Hold	7	–	–	﹤0.01%	1568
2025 Q3	$16	Hold	7	–	–	﹤0.01%	1314
2025 Q2	$14	Hold	7	–	–	﹤0.01%	1209
2025 Q1	$11	Hold	7	–	–	﹤0.01%	1197
2024 Q4	$13	Hold	7	–	–	﹤0.01%	1215
2024 Q3	$40	Hold	7	–	–	﹤0.01%	1176
2024 Q2	$57	Hold	7	–	–	﹤0.01%	1153
2024 Q1	$97	Sell	7 -1	-13%	-$9	﹤0.01%	1217
2023 Q4	$48	Hold	8	–	–	﹤0.01%	1176
2023 Q3	$37	Hold	8	–	–	﹤0.01%	1265
2023 Q2	$42	Hold	8	–	–	﹤0.01%	1280
2023 Q1	$77	Hold	8	–	–	﹤0.01%	1286
2022 Q4	$147	Hold	8	–	–	﹤0.01%	1287
2022 Q3	$0	Hold	8	–	–	﹤0.01%	1154
2022 Q2	$0	Hold	8	–	–	﹤0.01%	1154
2022 Q1	$0	Hold	8	–	–	﹤0.01%	1172
2021 Q4	$0	Hold	8	–	–	﹤0.01%	1198
2021 Q3	$1K	Hold	8	–	–	﹤0.01%	1079
2021 Q2	$1K	Hold	8	–	–	﹤0.01%	1056
2021 Q1	$1K	Hold	8	–	–	﹤0.01%	1019
2020 Q4	$1K	Buy	+8	New	+$1.06K	﹤0.01%	995

Other funds holding INO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

North Star Investment Management's INO Position: Q1 2026 in Review

North Star Investment Management held its Inovio Pharmaceuticals (INO) position steady in Q1 2026 at 7 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #1697.

North Star Investment Management first reported a position in INO in Q4 2020 and has held it in 22 quarters since. The position peaked at $1K in Q3 2021. 100 funds tracked by Wall St. Rank hold INO as of Q1 2026.

North Star Investment Management held 7 shares of Inovio Pharmaceuticals worth $12 as of Q1 2026.
North Star Investment Management left its Inovio Pharmaceuticals share count unchanged in Q1 2026.
Inovio Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1697 holding.
North Star Investment Management first reported a position in Inovio Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
North Star Investment Management's Inovio Pharmaceuticals position peaked at $1K in Q3 2021.
100 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.